trial · primary record
Barzolvolimab
Chronic Inducible Urticaria
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 240 |
| Primary completion | 2028-10 |
| Primary endpoint | Complete response to provocation testing at Week 12 |
| Registry ID | NCT07266402 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:58.621Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07266402
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- barzolvolimab · compound